Press release
Investigation announced for Investors in shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX) over potential Wrongdoing
An investigation on behalf of investors in Silverback Therapeutics, Inc. (NASDAQ: SBTX) shares over potential wrongdoing.
Investors who purchased shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Silverback Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Seattle, WA based Silverback Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.
On or around December 3, 2020, Silverback Therapeutics, Inc. conducted its initial public offering ("IPO"), offering 11.5 million shares of common stock priced at $21.00.
Then, on September 13, 2021, Silverback Therapeutics, Inc. issued a press release "announc[ing] that interim data from the dose-escalation portion of its Phase 1/1b clinical trial evaluating SBT6050 as a monotherapy and in combination with pembrolizumab in patients with advanced or metastatic HER2-expressing or amplified solid tumors will be presented at the upcoming European Society for Medical Oncology (ESMO) 2021 Congress from September 16-21, 2021" and advising that "[t]he accepted abstract . . . is now available on the ESMO website." Per the abstract, while there was a manageable safety profile for the Company's experimental therapy, the best overall response was PR (n=1), SD (n=3), and PD (n=10).
Shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX) declined to as low as $10.80 per share on September 23, 2021.
Those who purchased shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX) over potential Wrongdoing here
News-ID: 2444991 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Silverback
Digital Marketing Services Market Projected to Show Strong Growth | Conklin Medi …
Global Digital Marketing Services Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to…
Pay-per-click (PPC) AdvertisingMarket - Major Technology Giants in Buzz Again | …
The latest study released on the Global Pay-per-click (PPC) Advertising Market by AMA Research evaluates market size, trend, and forecast to 2027. The Pay-per-click (PPC) Advertising market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key…
Investigation announced for Long-Term Investors in Silverback Therapeutics, Inc. …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Silverback Therapeutics, Inc.
Investors who are current long term investors in Silverback Therapeutics, Inc. (NASDAQ: SBTX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: SBTX stocks follows a lawsuit filed against Silverback…
Deadline on January 4th coming up in Lawsuit for Investors in Silverback Therape …
A deadline is coming up on January 4, 2022 in the lawsuit filed for certain investors of Silverback Therapeutics, Inc. (NASDAQ: SBTX).
Investors who purchased shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX) have certain options and there are strict and short deadlines running. Deadline: January 4, 2022. NASDAQ: SBTX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District…
Lawsuit filed for Investors in shares of Silverback Therapeutics, Inc.
An investor, who purchased shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX), filed a lawsuit over alleged violations of Federal Securities Laws by Silverback Therapeutics, Inc.
Investors who purchased shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX) have certain options and for certain investors are short and strict deadlines running. Deadline: January 4, 2022.NASDAQ: SBTX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Seattle, WA based Silverback Therapeutics,…
Investigation announced for Investors in shares of Silverback Therapeutics, Inc. …
An investigation was announced over potential securities laws violations by Silverback Therapeutics, Inc. in connection with certain financial statements.
Investors who purchased shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Silverback Therapeutics, Inc. regarding its business, its prospects and its operations were…
